Renato Mantegazza Selected Research

Neuromuscular Junction Diseases

1/2022	Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management.
9/2017	Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renato Mantegazza Research Topics

Disease

42	Myasthenia Gravis 06/2022 - 01/2002
10	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2021 - 11/2002
9	Inflammation (Inflammations) 01/2020 - 09/2003
8	Fibrosis (Cirrhosis) 12/2018 - 11/2002
8	Muscular Dystrophies (Muscular Dystrophy) 01/2018 - 11/2002
7	Multiple Sclerosis 02/2022 - 12/2003
7	Thymoma (Thymic Carcinoma) 01/2018 - 07/2005
6	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2019 - 09/2003
4	Fatigue 01/2022 - 01/2018
4	Disease Progression 05/2021 - 01/2006
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 10/2009
3	Muscular Diseases (Myopathy) 01/2022 - 05/2010
3	Neuromuscular Diseases (Neuromuscular Disease) 05/2021 - 11/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2008
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 11/2020 - 01/2019
3	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 11/2019 - 09/2008
3	Inclusion Body Myositis 01/2018 - 10/2011
3	Neoplasms (Cancer) 09/2017 - 08/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2013 - 01/2006
3	Thymus Hyperplasia 08/2009 - 08/2003
2	Neuromuscular Junction Diseases 01/2022 - 09/2017
2	Pain (Aches) 01/2022 - 05/2013
2	Headache (Headaches) 01/2022 - 12/2017
2	Infections 05/2021 - 01/2018
2	Muscle Weakness 01/2021 - 01/2021
2	Channelopathies 01/2021 - 10/2016
2	Glycogen Storage Disease Type II (Pompe's Disease) 01/2021 - 01/2020
2	Laminopathies 01/2020 - 01/2018
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 03/2019 - 07/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2019 - 09/2013
2	Myotonia 01/2019 - 09/2013
2	Necrosis 12/2018 - 12/2011
2	Myotonia Congenita (Thomsen Disease) 10/2016 - 09/2013
2	Epstein-Barr Virus Infections 04/2016 - 01/2011
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 05/2014 - 11/2005
2	Anaphylaxis (Anaphylactic Shock) 04/2009 - 04/2008
2	Myositis (Idiopathic Inflammatory Myopathies) 06/2008 - 09/2003
1	Hyperkalemic Periodic Paralysis 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Fever (Fevers) 01/2022
1	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 01/2022
1	Muscular Atrophy (Muscle Atrophy) 05/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2021
1	Pulmonary Embolism 05/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
15	Cholinergic ReceptorsIBA 01/2021 - 02/2004
14	AntibodiesIBA 01/2021 - 10/2002
10	AutoantibodiesIBA 01/2021 - 04/2004
8	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2015
8	Pharmaceutical PreparationsIBA 01/2021 - 10/2002
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 06/2013
7	eculizumab FDA Link 01/2021 - 12/2017
7	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 07/2005
6	Immunoglobulin G (IgG)IBA 02/2022 - 09/2008
6	CollagenIBA 12/2018 - 11/2002
6	Peptides (Polypeptides)IBA 04/2009 - 10/2002
5	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022 - 02/2008
5	glucose-mannose-glucoseIBA 01/2021 - 01/2019
5	Messenger RNA (mRNA)IBA 01/2019 - 11/2002
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2021 - 08/2003
4	AmifampridineIBA 01/2021 - 12/2015
4	CytokinesIBA 01/2020 - 11/2002
4	Phosphotransferases (Kinase)IBA 01/2018 - 08/2008
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2006 - 11/2002
3	Complement System Proteins (Complement)IBA 06/2022 - 12/2017
3	EnzymesIBA 01/2021 - 01/2017
3	Interleukin-4 (Interleukin 4)IBA 01/2020 - 04/2009
3	Biological ProductsIBA 11/2019 - 12/2012
2	VaccinesIBA 02/2022 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 01/2020
2	SteroidsIBA 05/2021 - 05/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 03/2015
2	Immunoglobulin Fc FragmentsIBA 01/2021 - 01/2019
2	GlucosidasesIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	Complement Inactivating AgentsIBA 01/2020 - 12/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 02/2008
2	Epstein-Barr virus encoded RNA 1IBA 11/2017 - 01/2011
2	Azathioprine (Imuran)FDA LinkGeneric 01/2017 - 01/2013
2	Extracellular Matrix ProteinsIBA 01/2016 - 12/2011
2	DecorinIBA 05/2014 - 11/2005
2	Sarcoglycans (beta Sarcoglycan)IBA 05/2014 - 11/2005
2	DystrophinIBA 05/2014 - 06/2006
2	pixantrone (BBR 2778)IBA 05/2013 - 02/2008
2	muskIBA 01/2013 - 08/2008
2	AntigensIBA 01/2011 - 04/2008
2	Histidine DecarboxylaseIBA 04/2009 - 01/2006
2	Histamine (Histamine Dihydrochloride)FDA Link 04/2009 - 01/2006
2	DysferlinIBA 11/2005 - 09/2003
1	BNT162 VaccineIBA 02/2022
1	CalciumIBA 01/2022
1	PotassiumIBA 01/2022

Therapy/Procedure

16	Therapeutics 06/2022 - 01/2011
8	Activities of Daily Living (ADL) 01/2021 - 11/2017
6	Thymectomy 01/2018 - 08/2003
2	Immunotherapy 01/2020 - 03/2015
2	Precision Medicine 10/2019 - 10/2018
2	Plasma Exchange 12/2017 - 01/2009
2	Immunomodulation 12/2015 - 06/2006